Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 20, 2010, Pages 1714-1717

  Chen, Wenjing ^a   Li, Wujie ^a   Ling, Xiaomei ^a,b   Wang, Xiaowei ^a   Liu, Junyi ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Binding constant; Capillary electrophoresis; HIV reverse transcriptase; Nevirapine

Indexed keywords

ACETATE BUFFERS; ANALYTICAL METHOD; BINDING CONSTANT; HIV REVERSE TRANSCRIPTASE; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; QUANTITATIVE CHARACTERIZATION; SCATCHARD ANALYSIS; VIRUS REPLICATION;

BINDING ENERGY; BIOCHEMISTRY; BIOMOLECULES; CAPILLARY ELECTROPHORESIS; CHEMOTHERAPY; ELECTROCHEMISTRY; VIRUSES;

BINDING SITES;

BUFFER; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CAPILLARY ELECTROPHORESIS; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME BINDING; PH; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCATCHARD PLOT;

ELECTROPHORESIS, CAPILLARY; HIV REVERSE TRANSCRIPTASE; KINETICS; NEVIRAPINE; PROTEIN BINDING; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 77952743761     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.04.013     Document Type: Article

References (24)

1. Whitcomb J.M., and Hughes S.H. Annu. Rev. Cell Biol. 8 (1992) 275
2. Treesuwan W., and Hannongbua S. J. Mol. Graphics Model. 27 (2009) 921
3. Goff S.P. J. Acquir. Immune Defic. Syndr. 3 (1990) 817
4. Wu L., Zhang Q., Su L., Huang M.H., Zhao J.L., and Yang M.S. Sens. Actuators B 122 (2007) 243
5. Balzarini J. Curr. Top. Med. Chem. 4 (2004) 921
6. Kensch O., Restle T., Wohrl B.M., Goody R.S., and Steinhoff H.-J. J. Mol. Biol. 301 (2000) 1029
7. WHO, Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach - 2003 revision. Geneva, World Health Organization, 2003. Available at: http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf.
8. Mui P.W., Jacober S.P., Hargrave K.D., and Adams J. J. Med. Chem. 35 (1992) 201
9. Ren J., Nichols C.E., Chamberlain P.P., Stammers D.K., Weaver K.L., and Short S.A. J. Mol. Biol. 336 (2004) 569
10. Ren J.S., Milton J., Weaver K.L., Short S.A., Stuart D.I., and Stammers D.K. Structure 8 (2000) 1089
11. Stammers D.K., Somers D.O., Ross C.K., Kirby I., Ray P.H., Wilson J.E., Norman M., Ren J.S., Esnouf R.M., Garman E.F., Jones E.Y., and Stuart D.I. J. Mol. Biol. 242 (1994) 586
12. Parreira R.L.T., Abrahão O., and Galembeck S.E. Tetrahedron 57 (2001) 3243
13. Mager P.P. Med. Res. Rev. 17 (1997) 235
14. He X.Y., Ding Y.S., Li D.Z., and Lin B.C. Electrophoresis 25 (2004) 697
15. Zhou W., Kenneth B.T., and Morteza G.K. Anal. Biochem. 284 (2000) 334
16. Brown A., Morales C., and Gomez F.A. Talanta 74 (2008) 605
17. Sun H.W., and He P. Electrophoresis 30 (2009) 1991
18. Liang A.Y., He X.Y., Du Y.G., Wang K.Y., Fung Y.S., and Lin B.C. J. Pharm. Biomed. Anal. 38 (2005) 408
19. Kuno M., Hannongbua S., and Morokuma K. Chem. Phys. Lett. 380 (2003) 456
20. Juan A.A.S. Bioorg. Med. Chem. Lett. 18 (2008) 1181
21. Medina-Franco J.L., Rodríguez-Morales S., Juárez-Gordiano C., Hernández-Campos A., Jiménez-Barbero J., and Castillo R. Bioorg. Med. Chem. 12 (2004) 6085
22. Scatchard D. Ann. N. Y. Acad. Sci. 51 (1949) 660
23. He X.Y., Li D.Z., Liang A.Y., and Lin B.B. J. Chromatogr. A 982 (2002) 285
24. Liu J., Abid S., Hail M.E., Lee M.S., Hangeland J., and Zein N. Analyst 123 (1998) 1455